Trials / Sponsors / Antengene Therapeutics Limited
Antengene Therapeutics Limited
Industry · 4 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of ATG 037 Monother Locally Advanced or Metastatic Solid Tumors | Phase 1 | 2022-06-07 |
| Terminated | Safety and Preliminary Efficacy of ATG-017 Monotherapy or Combination Therapy With Nivolumab in Advanced Solid Solid Tumor, Hematological Malignancy | Phase 1 | 2020-08-15 |
| Terminated | A Study of Evaluating Dual Inhibitor of PAK4 and NAMPT ATG-019 in Advanced Solid Tumors or Non-Hodgkin's Lymph Solid Tumor, Non-Hodgkin's Lymphoma | Phase 1 | 2020-04-13 |
| Terminated | Dual TORC1/TORC2 Inhibitor ATG-008 (CC-223) in HBV Positive Advanced Hepatocellular Carcinoma (HCC) Subjects Hepatocellular Carcinoma | Phase 2 | 2018-08-07 |